Skip to main content
Erschienen in: Reactions Weekly 1/2019

01.10.2019 | Case report

Ixekizumab/secukinumab

Eczematous eruption: 4 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Napolitano M, et al. Eczematous eruption during anti-interleukin 17 treatment of psoriasis: an emerging condition. British Journal of Dermatology 181: 604-606, No. 3, Sep 2019. Available from: URL: http://doi.org/10.1111/bjd.17779 - Italy Napolitano M, et al. Eczematous eruption during anti-interleukin 17 treatment of psoriasis: an emerging condition. British Journal of Dermatology 181: 604-606, No. 3, Sep 2019. Available from: URL: http://​doi.​org/​10.​1111/​bjd.​17779 - Italy
Metadaten
Titel
Ixekizumab/secukinumab
Eczematous eruption: 4 case reports
Publikationsdatum
01.10.2019
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2019
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-019-68967-7

Weitere Artikel der Ausgabe 1/2019

Reactions Weekly 1/2019 Zur Ausgabe

Case report

Warfarin

Case report

Hypersexuality

Case report

Ibrutinib